Načítá se...
Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial
IMPORTANCE: Currently there is no drug therapy for abdominal aortic aneurysm (AAA). OBJECTIVE: To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA growth in the Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY) trial. DESIGN, SETTING, AND PARTICIPANTS:...
Uloženo v:
| Vydáno v: | JAMA Cardiol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Medical Association
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7450408/ https://ncbi.nlm.nih.gov/pubmed/32845283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.3524 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|